<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:AKBA (USA) Also Trade In: Germany

Akebia Therapeutics Inc $ 4.37 0.05 (1.04%)

Volume:
396,795
Avg Vol (1m):
825,747
Market Cap $:
528.93 Mil
Enterprise Value $:
427.01 Mil
P/E (TTM):
0.00
P/B:
1.04
Warning! GuruFocus has detected 3 Severe warning signs with AKBA. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

5.9/10
Current Vs Industry Vs History
Cash-To-Debt 3.93
Equity-to-Asset 0.63
Debt-to-Equity 0.07
Debt-to-EBITDA -0.15
N/A
Piotroski F-Score 1
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.54
DISTRESS
GREY
SAFE
Beneish M-Score 191.58
Not Manipulator
Manipulator
WACC vs ROIC
ROIC -179.15 %
WACC 13.32 %

Profitability

1/10
Current Vs Industry Vs History
Operating Margin % -88.48
Net Margin % -75.64
ROE % -53.37
ROA % -30.71
ROC (Joel Greenblatt) % -1272.62
3-Year EBITDA Growth Rate -9.3
3-Year EPS without NRI Growth Rate -2.6

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -23.7

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 3.4
Price-to-Median-PS-Value 0.58
Earnings Yield (Greenblatt) % -59.3